We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Different Methods Compared for Diagnosis of Clostridium difficile Infection

By LabMedica International staff writers
Posted on 09 Aug 2011
Four diverse methods were evaluated for the detection of Clostridium difficile in stool specimens collected in liquid transport medium. More...


The methods for detection included an enzyme immunoassay for the antigen glutamate dehydrogenase (GDH), a toxin A and B enzyme immunoassay (Toxin EIA), cell culture cytotoxicity neutralization assay (CT) and a real time polymerase chain reaction (PCR) assay.

Scientists from the University of Michigan Health System (Ann Arbor, MI, USA) analyzed a total of 357 stool specimens collected in Cary-Blair transport media (Meridian Diagnostics, Cincinnati, OH, USA). The goal of their study was to establish an analytically accurate and efficient algorithm for the detection of C. difficile infection (CDI) in a patient population using samples collected in a specific transport medium and to determine whether the sensitivity and specificity of PCR was affected by freezing samples before testing.

The analytic sensitivity and specificity of each as determined using a combined gold standard were as follows: for the Wampole C. DIFF CHEK-60 Assay, GDH (Inverness Medical; Princeton, NJ, USA) were 100% and 93.2%, respectively; for the C. difficile Toxin A/B Microplate Assay, Toxin EIA (Remel; Lenexa, KS, USA) were only 82.9% for both. The cell culture cytotoxicity neutralization assay (TrinityBioTech; Carlsbad, CA; USA) achieved 100% sensitivity and specificity, while for the PCR that was performed on frozen specimens, they were 74.3% and 96.6%, respectively. However, the sensitivity and specificity of the GeneOhm Cdiff PCR Assay improved to 100%, when performed on 50 fresh stool samples collected in Cary-Blair media. This molecular assay is a product of Becton, Dickinson and Company (Franklin Lakes, NJ, USA).

Clostridium difficile infection (CDI) caused by toxigenic strains of C. difficile is primarily a nosocomial infection with increasing prevalence. The authors concluded that while CT remains a sensitive method for the detection of CDI, GDH offers an excellent initial screening method to rule out CDI. The authors concluded that while the performance of each assay did not appear to be affected by collection in Cary-Blair medium, the PCR method performed better using fresh specimens. While PCR on all stool specimens currently carries a high cost per test, this method may offer a more rapid alternative to CT for the confirmation GDH-positive samples. The study was published in July 2011 in the online journal Infectious Disease Reports.

Related Links:

University of Michigan Health System
Meridian Diagnostics



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Hemodynamic System Monitor
OptoMonitor
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: A diagnostic test can distinguish patients with head and neck squamous cell carcinoma who can be cured with surgery alone (Photo courtesy of University of Turku)

Novel Diagnostic Tool to Revolutionize Treatment Guidance of Head and Neck Cancer

Head and neck squamous cell carcinoma (HNSCC) is a solid tumor type commonly treated with surgery. However, there has been no clinically available method to determine which patients can be cured with surgery... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: The 3D paper-based analytical device has shown high clinical accuracy for adult-onset immunodeficiency (Photo courtesy of National Taiwan University)

Paper-Based Device Accurately Detects Immune Defects in 10 Minutes

Patients with hidden immune defects are especially vulnerable to severe and persistent infections, often due to autoantibodies that block interferon-gamma (IFN-γ), a key molecule in immune defense.... Read more

Pathology

view channel
Image: The smart microscope can predict the onset of misfolded protein aggregation, a hallmark of neurodegenerative diseases (Photo courtesy of EPFL)

Self-Driving Microscope Tracks and Analyzes Misfolded Protein Aggregation in Real Time

The accumulation of misfolded proteins in the brain is central to the progression of neurodegenerative diseases like Huntington’s, Alzheimer’s, and Parkinson’s. Yet to the human eye, proteins that are... Read more

Technology

view channel
Image: The Check4 gene-detection platform (Photo courtesy of IdentifySensors)

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells

A major challenge in healthcare is the early and affordable detection of serious diseases such as cancer. Early diagnosis remains difficult due to the complexity of identifying specific genetic markers... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.